Home > Healthcare > Medical Devices > Medical Supplies > Intrauterine Devices Market

Intrauterine Devices Market - By Product (Copper IUD, Hormonal IUD), By Age Group (15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45+) & Global Forecast, 2023-2032

  • Report ID: GMI5451
  • Published Date: Mar 2023
  • Report Format: PDF

Intrauterine Devices Market Size

Intrauterine Devices Market size was valued at over USD 4 billion in 2022. Driven by the growing instances of unwanted pregnancies across the globe, the market is slated to grow at over 6% CAGR from 2023 to 2032. 

Intrauterine Devices Market

As per the UN’s sexual and reproductive health agency, UNFPA, the world reports about 121 million unwanted pregnancies annually, which represents nearly 50% of all pregnancies. Many of such pregnancies occur due to reproductive coercion, sexual violence, unawareness about sexual and reproductive healthcare, resulting in various health complications and financial implications.

Meanwhile, growing awareness about family planning has also increased the demand for intrauterine devices in recent years. These devices are reliable for contraception and can last for up to 5 years or more. They are also easy to use, reversible in nature, efficient, and ideal for long-term use.

Health complications related to IUDs may restrain industry development

Despite various benefits offered by IUDs, the potential health risks associated with their regular use may impede product adoption, hampering intrauterine devices market progress. Studies have shown that an IUD may slightly increase the chances of infection to the fallopian tubes, uterus, or ovaries, resulting in pelvic inflammatory disease (PID). In fact, as per the NCBI, chances of PID are 2-5 times higher in IUD users, specifically common in women aged between 15-19 than in women who use other contraception methods such as barrier technique or oral contraceptives. 

Intrauterine Devices Market Analysis

Global Intrauterine Devices Market Share, By Product

Based on product, the intrauterine devices market share from hormonal IUD segment is poised to depict a CAGR of more than 6.5% over 2023 - 2032. Hormonal IUDs such as Mirena™ and Kyleena™ can be used for up to 5 years without complications. They are regarded as quite safe and are suitable for people with heavy menstrual flow, fibroids, anemia, and endometriosis. In fact, there have been very few instances where users have experienced vaginal bleeding after its insertion. The other benefits of hormonal IUDs include less painful menstrual cycles, low risk of pelvic inflammatory disease (PID), less bleeding, and long-term contraception, among others.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for intrauterine devices recorded a valuation of USD 4 billion in 2022 and is anticipated to grow at 6% CAGR from 2023 to 2032, driven by the rising cases of unintended pregnancies worldwide.

Hormonal IUD industry is expected depict a growth rate of more than 6.5% over 2023 – 2032 due to the product being a long-term solution for pregnancy prevention.

Asia Pacific intrauterine devices market is set to exhibit over 6.5% CAGR from 2023 to 2032, fueled by surging government efforts to bring the cost of available IUDs down.

The major intrauterine devices suppliers include names such as OCON Medical Ltd., HLL Lifecare Limited, Durbin, Gima S.p.A., Prosan International BV, Pregna International Ltd., Eurogine S.L., SMB Corporation of India, and Meril Life Sciences Pvt. Ltd., among others.

Intrauterine Devices Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 205
  • Countries covered: 30
  • Pages: 170
 Download Free Sample